KENNEWICK, Wash., Jan. 15, 2008 (PRIME NEWSWIRE) -- dvanced Medical Isotope Corporation of Kennewick, Wash. (AMIC) (Pink Sheets:ADMD) announced the execution of a five-year agreement with Central Pharmaceutical Services, Inc. (CRS) for the joint production and marketing of Indium-111, an isotope used in specialized diagnostic imaging applications. By labeling In-111 to antibodies and peptides that transport it to specific parts of the body, physicians can image colorectal cancer, prostrate cancer, and neuroendocrine tumors. In-111 can also be used to radiolabel white blood cells, platelets and red blood cells for diagnostic purposes.
